Human embryonic stem cells (hESCs) can be induced and differentiated to form a relatively homogeneous population of neuronal precursors in vitro. We have used this system to screen for genes necessary for neural lineage development by using a pooled human short hairpin RNA (shRNA) library screen and massively parallel sequencing. We confirmed known genes and identified several unpredicted genes with interrelated functions that were specifically required for the formation or survival of neuronal progenitor cells without interfering with the self-renewal capacity of undifferentiated hESCs. Among these are several genes that have been implicated in various neurodevelopmental disorders (i.e., brain malformations, mental retardation, and autism). Unexpectedly, a set of genes mutated in late-onset neurodegenerative disorders and with roles in the formation of RNA granules were also found to interfere with neuronal progenitor cell formation, suggesting their functional relevance in early neurogenesis. This study advances the feasibility and utility of using pooled shRNA libraries in combination with next-generation sequencing for a high-throughput, unbiased functional genomic screen. Our approach can also be used with patient-specific human-induced pluripotent stem cell-derived neural models to obtain unparalleled insights into developmental and degenerative processes in neurological or neuropsychiatric disorders with monogenic or complex inheritance.
Human embryonic stem cells (hESCs) can be induced and differentiated to form a relatively homogeneous population of neuronal precursors in vitro. We have used this system to screen for genes necessary for neural lineage development by using a pooled human short hairpin RNA (shRNA) library screen and massively parallel sequencing. We confirmed known genes and identified several unpredicted genes with interrelated functions that were specifically required for the formation or survival of neuronal progenitor cells without interfering with the self-renewal capacity of undifferentiated hESCs. Among these are several genes that have been implicated in various neurodevelopmental disorders (i.e., brain malformations, mental retardation, and autism). Unexpectedly, a set of genes mutated in late-onset neurodegenerative disorders and with roles in the formation of RNA granules were also found to interfere with neuronal progenitor cell formation, suggesting their functional relevance in early neurogenesis. This study advances the feasibility and utility of using pooled shRNA libraries in combination with next-generation sequencing for a high-throughput, unbiased functional genomic screen. Our approach can also be used with patient-specific human-induced pluripotent stem cell-derived neural models to obtain unparalleled insights into developmental and degenerative processes in neurological or neuropsychiatric disorders with monogenic or complex inheritance.
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Mendelian disorders of the nervous system
O ur general aim is to identify genes and pathways of early neural differentiation that are relevant for the development and function of the human nervous system. In vitro differentiation of human embryonic stem cells (hESCs) yielding developmentally competent neuronal progenitors is an attractive model for these studies and several approaches for this have been developed, including those by our group (1) .
Large-scale loss-of-function analysis by RNA interference (RNAi) using small hairpin (shRNA) or small interfering RNA (siRNA) -mediated knockdown of genes is a powerful screening approach in mammalian cells (2) (3) (4) (5) (6) (7) . ShRNAs provide the opportunity for long-term silencing by stable infection of cells maintained under selection pressure. Furthermore, pooled libraries of shRNAs can be efficiently used instead of arrayed individual clones. Screening experiments can be designed for detection of shRNAs that produce a desired effect in a cell (positive screens) or for the depletion of shRNA species that silence a necessary gene (dropout screens). The abundance of shRNAs has been measured by using barcodes and array hybridization (8, 9) , but this procedure is subject to cross-hybridization and nonlinear responses. Most positive screens have been limited to studies of cellular proliferation or survival because it is easier to analyze the recovered enriched shRNAs (10) . For dropout screens it is critical to accurately measure the abundance of shRNAs that are retained in cells at the end of the experiment to determine which shRNAs were depleted (8) . In part because of this challenge, the advantage of dropout screens to decipher genes and pathways based on a more complex phenotype has not been exploited. We and others have begun using next-generation sequencing for quantitating shRNAs present in a cell population for dropout shRNA screens (3, 11) . Sequencing has a very wide dynamic range for detecting shRNAs, and allows for the discovery of mutant shRNAs that might confound analyses. ShRNA libraries should also avoid off-target effects as well as ineffective shRNAs (12) . Each individual shRNA should be infected into a minimum of >300 cells so that the recovery of each shRNA will not be distorted because of the variation in the number of infected cells.
We have developed an efficient phenotype-based strategy using pooled shRNA libraries and massively parallel sequencing to identify genes that play a specific role in the neural lineage development of hESCs. We demonstrate here the practicality of this screening approach and describe the unexpected finding that several genes specifically required for neural commitment and neural progenitor maintenance encode proteins that are associated with various forms of RNA granules and are implicated in distinct neurological disorders, including diseases presenting with late-onset neurodegeneration.
Results
Pooled Human shRNA Library Screen to Identify Genes of Neural Lineage Commitment in hESCs. We established and modified procedures for high-throughput studies to expand hESCs and induce a nearly uniform differentiation of these cells into NESTIN, SOX2, PAX6, and polysialylated neural cell adhesion molecule (PSA-NCAM)-positive neural precursors (NPCs) using the bone morphogenic protein antagonist, noggin, and fibroblast growth factor 2 (FGF2) (1, 13) . We used a commercial, pooled wholegenome lentiviral shRNA library developed by the Broad Institute [The RNA1 Consortium (TRC)/Mission LentiPlex; Sigma] to search for genes that promoted or limited neural commitment and differentiation of hESCs (Fig. 1A) . The full genome library is divided into 10 pools; we chose one pool containing 8,488 individual shRNAs targeting 1,801 genes (an average of four to five shRNAs per gene). The shRNA gene targets in this pool were diverse but enriched for transcription factors [P < 0.00001 by Gene Ontology (GO) categories]. The titration of the pLKO.1 shRNA virus infection was based on development of puromycinresistant colonies.
A single-cell suspension of 1 × 10 8 undifferentiated H1 hESCs was infected with the library at a multiplicity of infection of 0.3 to obtain more than 300 single-copy infection events per shRNA. A portion of the culture (5× 10 7 cells) was harvested 2 d after the infection (time 0, T0) and the remaining cells were propagated for an additional 3 d under puromycin selection, then separated into two large pools representing separate arms of the screen (Fig. 1B) . In one arm the infected cells were maintained as undifferentiated hESCs for an additional 4 wk and in the other arm the cells were induced to differentiate into NPCs by exposure to noggin for 14 d, followed by plating the cells onto a polyornithine/ fibronectin matrix, then culturing for an additional 2 wk with a low concentration of FGF2. The cells were under puromycin selection throughout (Fig. 1B) . At the end of neural differentiation the NPC population was separated from undifferentiated cells (or cells acquiring nonneural fate) by preparative FACS using the cell-surface marker PSA-NCAM (14, 15) . A monoclonal antibody against the two to eight linked neuraminic acid polymer (PSA) moiety specifically labels a spectrum of neural cells, making it possible to identify genes necessary for early neural differentiation. Based on the PSA-NCAM expression, the differentiated cells were binned into three groups: PSA-NCAM absent, weak-positive, and strong-positive ( Fig. S1 A and B) . We focused on the PSA-NCAM-negative and strong-positive groups.
The sorted cells (ranging from 4.6 × 10 5 to 4.9 × 10 6 cells for each group) were collected and genomic DNA was prepared. In the undifferentiated arm of the screen a time-course experiment was performed (T1 through T5) (Fig. 1B) . The shRNA-encoding inserts from each of the cell populations were recovered by a single-step PCR using sufficient gDNA to faithfully represent the entire library pool (Fig. S1C) . The PCR products were subjected to deep sequencing, yielding a minimum of 10 million postfilter reads per sample (Table S1 ) to quantify the frequencies of the various shRNA species.
Gene Target Identification. We developed a bioinformatics pipeline for annotation and quantification of the sequence reads. Correct sequence initiation was higher than 99% and the number of the reads mapped to the library's sequence database was higher than 96%. A small fraction of the shRNAs (1.7% of the genes in the pool) was not used because of difficulties with gene annotation using the National Center for Biotechnology Information Reference Sequence Database (release 56).
At 48 h after infection (T0), more than 94.5% of initial shRNAs were detected. The absence of certain shRNAs could be because of defectiveness of the original viral library or early cellular toxicity of these shRNAs. The distribution of reads per shRNA followed an approximately Gaussian curve. Similar patterns were seen from pooled shRNA-infected PSA-NCAM-sorted cells and from undifferentiated cells grown for 4 wk (Fig. S1D ). Approximately 15% of the shRNAs dropped out in the undifferentiated arm at 4 wk (T5), representing shRNAs that were either toxic or targeted genes that were needed for pluripotency and caused differentiation (into any lineage), preventing expansion of undifferentiated cells. Nonsilencing shRNA sequences seeded into the initial library pool were recovered at a similar abundance in each group. These results indicate the effectiveness of the protocol for infecting hESCs and for recovery of shRNA inserts.
The representation of all shRNAs was quantified as the ratio of the number of reads for that shRNA to the total number of mapped reads from that condition and this ratio was then log-transformed. Reads <100 were considered as background. A scatterplot of normalized reads per shRNA between PSA-NCAM-negative and PSA-NCAM strong-positive cells after neural differentiation showed that shRNAs targeting known genes essential for neural stem/progenitor cell maintenance and self-renewal, exemplified by BMI1, are depleted in the PSA-NCAM strong-positive compared with the PSA-NCAM-negative group (Fig. 1C) . Among the targets of significantly depleted shRNAs were a group of genes encoding components of RNA granules [TAR DNA binding protein (TARDBP), polyglutamine binding protein (PQBP1), and TIA1 cytotoxic granule-associated RNA binding protein-like 1 (TIAL1), see below] (16, 17) . ASCL1 (MASH1), a transcription factor with critical roles in neuronal commitment and in fibroblastneuron in vitro transdifferentiation was essential for hESC-derived neural lineage development (18) . Enrichment of shRNAs during NPC generation is illustrated by shRNAs silencing ING5, a tumor suppressor protein that inhibits growth of various cell types (19) .
Gene Target Classification. Gene hits were scored by criteria similar to those used in other recent work (3, 20) , according to whether there was a progressive change of 1.7-fold of normalized shRNA read abundance for at least two shRNAs targeting the given gene, with no shRNA showing a contradictory change, or whether shRNAs disappeared entirely from all cell phenotypes after differentiation (Table S2 ). The 1.7-fold on the log 2 plot represents almost two SDs, so that a point above 1.7-fold the mean value has less than between a 5% and 6% chance of being a result of chance. Based on this analysis the percentages of targeted genes with respect to all genes of the pooled library were compared ( Fig. 2A) . ShRNAs targeting 4.2% of all genes displayed a gradual depletion when PSA-NCAM strong-positive cells were compared with the PSA-NCAM-negative population (Depleted), but 7.4% of the gene targets were enriched in PSA-NCAM strong-positive cells (Enriched). Depleted hits may represent genes that normally function in hESC neural lineage fate commitment, NPC maintenance, and differentiation, but could also include genes involved in cellular proliferation and survival. Enrichment of NPCs may imply that the targeted gene normally delays NPC generation or promotes early exit and terminal neuronal differentiation, but may also include effects, such as depletion of essential genes for endoderm or mesoderm lineage specification, leading to default neural differentiation. ShRNAs for nearly 20% of the genes were fully eliminated in both PSA-NCAM-negative and weak or strong-positive cells (Absent), implying that these genes had essential roles in early neural lineage specification, NPC survival, or general cellular survival.
The quantitative analysis of shRNA reads used both individual data review and a statistical method (RIGER) designed for the TRC shRNA library (21, 22) . We used the Second Best Rank feature of RIGER, which requires that two different shRNAs result in the same effect. The RIGER analysis displayed a good concordance with the shRNA target hits obtained by our selection strategy (Fig. 2B) . Among the 74 gene hits reported by our criteria to result in depletion in PSA-NCAM-positive cells, 42 were among the top 75 genes and all of the 74 genes were within the top 9% of genes categorized by RIGER analysis (Fig. 2B,  Upper) . The RIGER ranking and our selection strategy also agreed for genes whose shRNA was enriched in the PSA-NCAM-positive cells (Fig. 2B, Lower) .
The undifferentiated arm of the screen confirmed if the gene hits detected were specific to neuronal differentiation. We compared the changes in shRNA representation during neural differentiation with the abundance of those shRNAs in the undifferentiated cells and categorized each gene target by the described preset criteria (Table S2) . We used the Fisher twotailed exact test (23) to calculate the likelihood that the results of measurements in these two conditions could have arisen by chance from two samples taken from the same pool. Gene targets whose shRNA's abundance changed significantly during neural differentiation were more likely unchanged in the pluripotent arm of the screen (Table 1) . That is, the neural differentiation-specific genes were significantly more prevalent (P < 0.0001) in the Depleted, Absent, and Enriched gene-target categories than in the Unchanged group.
Target Genes Are Enriched for Components of RNA Granules and Nervous System-Related Genes. We performed a systematic, manual curation of the literature for genes to identify those related to nervous system functions, including neurogenesis, neural development, brain-specific functions, and nervous-system disorders. There was a significant enhancement for nervous system-related genes in each category of genes whose shRNAs displayed changes (i.e., Depleted, Absent, or Enriched) (Table S3) . Protein:protein interaction analysis by DAPPLE (Disease Association ProteinProtein Link Evaluator) (24) of all genes that displayed gradual shRNA depletion during neuronal differentiation revealed that genes with known/presumed neural system-related functions may functionally interact or converge within the same cellular pathway in a significant manner (Fig. S2) .
The 74 genes whose shRNAs were depleted from the PSA-NCAM strong-positive cells compared with shRNA abundances in the PSA-NCAM-negative population (Depleted) (Figs. 1C and 2 ), might be needed specifically for differentiation of neural precursor cells but are less critical for general cellular growth. shRNAs for 60 of these genes were not significantly depleted in the undifferentiated arm over 5 wk of cell growth (Table 1 , Depleted, and Fig. S3 ). GO classification of the 74 gene targets showed significant enrichment for transcriptional repressors and for products associated with intracellular membrane-free organelles (Table 2) .
Among these targets were a number of genes with established roles in neural stem/progenitor cell self-renewal, neural fate determination, and neurogenesis (for example BMI1, NEUROD1, MBD1, REST, HELT). Several of the 74 genes are implicated in disorders of the human nervous system, including childhood neurodevelopmental disorders, such as Autism spectrum disorders (ASD), syndromic and nonsyndromic mental retardation (MR), and late-onset neurodegenerative processes, including frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and Huntington and Parkinson diseases (Table S4 ). Several genes within this group, including TARDBP, TIAL1, SIRT1, and PQBP1, which have recently been implicated in neurodegenerative diseases (ALS/FTLD spectrum, SMA, Lewy Body Dementia, Parkinson disease, MR, respectively), are involved in mRNA trafficking, stability, and microRNA biogenesis, associated with various types of RNA granules or involved in protein misfolding (25, 26) . Silencing of additional genes within these pathways (e.g., G3BP1, TAF15, and SNRPB2) in our shRNA screen displayed different PSA-NCAM phenotypes (Table S5) , in line with the interaction and differential regulation of RNA granule components (27) .
The 354 genes whose shRNA disappeared entirely during neural differentiation (Absent group) included target genes with fundamental general cellular functions. A significant decrease or loss of their shRNAs was also seen in the undifferentiated hES cells (e.g., BUD31, POLR21, RAD52, PTTG1, among others). More than 100 of the 354 genes, many of them multifunctional transcriptional regulators, have key functions in the developing or mature nervous system. About half of those genes showed specificity for the neural differentiation arm of the screen, as the same shRNAs failed to interfere with the growth of undifferentiated hESCs (Table S6 ). This group included not only targets where gene silencing might lead to loss of early neural fate commitment (e.g., HESX1, NEUROG3, SMAD6, EOMES), but also genes involved in terminal neuronal specification or function (e.g., FOXP1, ETV1, AKAP1 or ERCC6). Overall, these findings strongly support the biological validity of the screening approach. (Table S2 ). Unchanged category: all gene targets whose shRNAs abundances were not changed when comparing PSA-NCAMnegative and strong-positive cell fractions or whose pattern of change was ambiguous. Absent: gene targets whose shRNAs were absent in all PSA-NCAM sorted cell populations at the end of neural differentiation. Enriched and Depleted: genes whose shRNAs were enriched or depleted, respectively, in PSA-NCAM strong-positive cells vs. PSA-NCAMnegative cells at the end of neural differentiation. (B) Concordance of the manual classification and the RIGER ranking of gene targets. RIGER analysis of shRNA abundances recovered from PSA-NCAM strongpositive vs. negative cell populations after neural differentiation was performed. The figure shows overrepresentation of Depleted (Upper) and Enriched group (Lower) of genes selected by manual classification at the two extremes of the RIGER-ranked list of genes displayed in a 200-gene sliding window. The dotted line indicates the total overlap, expected by chance, between the genes we scored as depleted or enriched in the PSA-NCAM-positive cells and the entire set of ranked genes in the RIGER dataset. The x axis is the ranking order of genes by RIGER. The y axis is the fraction of genes.
Screen Validation by Individual Gene Silencing. Intrigued by the enrichment of target genes encoding components of RNA granules and implicated in neurodegenerative disorders, we selected a set of gene hits for further study from the Depleted and Absent categories, including TARDBP, PQBP1, TIAL1, and genes with proposed neuronal stem/progenitor cell functions, such as BMI1, CCR4-NOT transcription complex, subunit 4 (CNOT4), and LIM domain only 3 (LMO3). Individual viral shRNAs (two to three per gene) in the same vector backbone were used. We followed the procedure for pooled shRNA library screening with cells cultured in two different conditions (pluripotent ES propagation vs. NPC differentiation). We monitored both the morphological features of the cells and the silencing of the respective genes by quantitative RT-PCR (qRT-PCR) along with analysis of PSA-NCAM expression by immunofluorescence and NCAM1 mRNA expression. Furthermore, we analyzed the development of additional typical markers of neuronal progenitors, such as NESTIN and SOX1, by immunostaining. The efficiency of knockdown by the individual shRNAs is shown in Fig.  3A . Among 13 individual shRNAs tested, 10 showed substantial knockdown (40-95%) both in cells grown as pluripotent hESCs and in differentiated NPCs, and one shRNA showed knockdown only in hESCs but not in the corresponding NPC. Because the cell number decreased during differentiation, we had limited numbers of cells for most of the shRNA targets and therefore used a modified RT-PCR protocol amenable for small number of cells ,000 per well) (28) (SI Methods). In a few cases we obtained fewer than 20 cells and were unable to accurately assess mRNA expression (Fig. 3 A and B, diamonds) .
We confirmed the effects of shRNAs on neural differentiation by measuring NCAM1 mRNA expression levels of cells differentiated to NPCs using real time qRT-PCR (Fig. 3B) . Eight of nine shRNAs resulted in significantly decreased NCAM1 mRNA expression compared with nonsilencing controls. This process validated the PSA-NCAM-based phenotypic selection of the screen.
Most of the shRNA-transduced cells had slower growth rates when we began NPC differentiation and this became more pronounced when we transferred the cells into polyornithine/ fibronectin-coated surface, as illustrated with one of the shRNA's targeting TARDBP (Fig. 3C) . When the infected cells were propagated in pluripotent conditions, they grew comparably to the nonsilencing control shRNA infection, except that one of the two LMO3 shRNAs caused rapid cell death in both undifferentiated and differentiated cells. Immunostaining experiments using the more general neuronal stem/progenitor markers NESTIN and SOX1 showed that cells differentiated into NPCs from hESCs as completely as the untreated culture (Fig. 3E) (control shRNA)  (1, 13) . Furthermore, in most cases after targeting shRNAs the cells preserved their defining markers, NESTIN and SOX1, even though the PSA-NCAM expression was decreased in these unsorted cultures (see Fig. 3 D and E for a representative example of the TARDBP knockdown phenotype). For several of the shRNAs, impaired proliferative capacity and survival might explain the depletion of cells harboring the given shRNA. In one case, the infected cells failed to fully express all classic NPC markers, suggesting the alternative of a perturbed fate specification. To rule out cell-line specificity, similar experiments were performed in a second hESC line, H9, and the results agreed with the H1 experiments (Fig. S4) .
Enrichment of Hits for Genes Implicated in Autism and Intellectual
Disability. Among the unexpected findings of our unbiased shRNA screen was an enrichment of gene hits the encoded proteins of which are integral parts of RNA granules, hence implicated in normal neural commitment and neuronal progenitor differentiation of hESCs. Mutations of several of these and other genes that emerged from the screen are associated with neurodevelomental and neurodegenerative disorders affecting higher cortical functions. To evaluate if additional genes involved in neurodevelopmental disorders were uncovered by this functional screen, we took advantage of independent, large scale, and reproduced genomic studies [genetic association, copy number variation (CNV) analysis, and whole exome sequencing] of human genotypes to decipher the genetic architecture of ASD and nonsyndromic MR (SI Methods). The derived candidate gene set (representing de novo and recurrent single mutations and CNVs) was cross-referenced with the entire gene list targeted by the viral pool and with the gene targets identified and classified in the neural differentiation arm of the screen (Fig. 2A) . There was an enrichment of ASD and nonsyndromic MR/intellectual disability gene targets among those genes whose shRNA abundances were significantly changed during neural differentiation (Table 3 and Table S7 ). This finding provides a functional correlate for the gene-mapping data and opens the possibility for detailed mechanistic studies related to the mutations and pathways in these disorders. Furthermore, this result may provide a framework to integrate and harness independent, large-scale datasets from quite distinct genomic approaches.
Discussion
There are technical difficulties in using hESCs and shRNA libraries to study in vitro neural differentiation. The infective titer for standard lentiviral vectors may be lower in ES cells than in cells 
Gene hit category
Gene hit categories
Gene hit categories were defined as in Fig.2A , based on the quantitative shRNA read analyses of PSA-NCAM-sorted cell phenotypes after neuronal differentiation (Table S2 and SI Methods). Neural differentiation-specific genes were defined by the ratio of shRNA abundance in the PSA-NCAMpositive versus -negative cells at the end of neural differentiation (neural differentiation arm) with the requirement that their respective shRNA abundances did not change in cells infected by the same shRNA library pool and maintained in pluripotent culture conditions for the same duration (parallel undifferentiated arm) (Fig. 1B) . The relative proportion of these neural differentiation-specific gene targets was then compared between the different phenotypic categories (as defined at the end of neural differentiation) by using the Fisher two-tailed exact test for 2 × 2 contingency tables. The P values shown in boldface indicate significant differences and show an enrichment of neural differentiation specific genes in hits categories defined by changes in shRNA abundance during neural differentiation. Table 2 . GO analysis of gene targets whose shRNAs became depleted during neuronal differentiation
GO category
Adjusted P value Example
Transcription corepressor activity P = 0.038 SIRT1, TLE1, CITD2 Nonmembrane-bounded organelle P = 0.035 PFDN5, GABPA, TARDBP, PQBP1, REST Intracellular nonmembrane-bounded organelle P = 0.035 PFDN5, GABPA, TARDBP, PQBP1, REST, TRIM28, ZNF44
A total of 74 genes were analyzed by Database for Annotation, Visualization and Integrated Discovery (DAVID) using the entire gene collection targeted by the shRNA pool as input.
such as HEK293 or HeLa. The hESCs are grown in monolayers rather than in suspension cultures and the undifferentiated cells have to be manually selected for passage. The experiments have to be carried out for a longer time than is used for most large-scale shRNAscreens. The present work shows that these studies are feasible using cell-type specific, phenotype-based approaches, rather than lethality readout. The use of more cells, and libraries with higher coverage (more shRNA species per gene) with inserts that have been more extensively screened for effectiveness and lack of target effects will be of great value, and could increase the fraction of true positive hits and the efficiency of subsequent target verification.
One of the observations from the present study is that many of the shRNA targets depleted in the more differentiated PSA-NCAM-positive neural precursors permitted normal growth of undifferentiated hESCs, even when the gene expression was substantially reduced, but became essential for differentiation and survival under conditions that induced neural differentiation. One caveat is that the differentiation procedure involves passaging of cells that might be stressful independent of neural differentiation. Nevertheless, the specific enrichment for genes with known neural system-related functions among the PSA-NCAM-positive dropouts indicates that a major part of the selection was directly related to neural differentiation.
Depletion of shRNAs targeting a particular gene could arise because of the shRNA promoted differentiation into some nonneuronal type of cell, or perhaps more commonly, because the gene product was needed for the differentiation or survival of neural cells. Most (12 of 13) of the shRNAs against dropout genes that were retested permitted the undifferentiated ES cells (two different ES lines) to grow essentially normally, but produced fewer cells when cultured in low FGF environment to generate and maintain neural progenitors.
TIALl, TARDBP, and PQBP1 are an interesting group and a number of other RNA granule components have emerged as altering NPC generation in our screen, including members of a family of proteins that contain RNA binding domains and a patch of glutamine and asparagine rich amino acid sequences (prionrelated domains) (29) . Polyglutamine regions are associated with formation of prion-like structures in organisms from yeast to man. These proteins play a role in RNA splicing and export, control of translation, and sequestering of RNA molecules, perhaps related to the ability of prion-related domains to form aggregates. Depletion of TARDBP both impairs stress granule formation (30) and makes the cells more vulnerable to arsenite-mediated stress. PQBP1 is a polyglutamine tract binding protein that lacks an asparagine and glutamine rich cluster but can also form nuclear inclusions and is a component of other RNA granule types, such as neuronal RNA granules and stress granules (31) . The molecular links to how mutations of these proteins lead to distinct neuropathological changes are unresolved and their precise role in embryonic or adult neuronal stem/progenitor cell function in physiological (or pathological) conditions is unknown. It is tempting to think that RNA granule genes are required specifically for normal human neural development, neural stem/ progenitor maintenance, and function. One may contemplate that perturbed interaction between these proteins (such as due to mutations) and RNA granule dysfunction result in an early cellular vulnerability that can lead to neurological disease. The cellular role of various genes implicated in ASD, MR, and neurodegenerative disorders is just emerging and very little is known of the specific effects at the level neural stem cells. Perhaps impairment of genes used in early neural differentiation makes the CNS more vulnerable to either genetic or environmental disturbances during development or in adulthood, resulting in later-onset manifestations. If these early genes are turned on as part of a defensive reaction to neural damage, removing their proteins would make the cells susceptible to injury.
Another interesting conclusion of our study is that a number of genes that have been implicated in terminal aspects of differentiation, maintenance of mature neurons, or late-onset neurologic disorders may also function at early stages of neural commitment and specification. Mutations in these genes could have pleiotropic effects on the nervous system, depending on the genetic environment and the specific mutation.
Overall, the approach to shRNA screening we describe here has impressive potential to uncover lineage-specific gene functions. In particular, it should be valuable to conduct such screens in ES or induced pluripotent cells bearing disease-specific mutations. Further, genetic interaction studies of combinations of shRNAs (32) identified in these screens to delineate functional pathways in neural differentiation and maintenance could be particularly informative.
Methods
HESCs (H1 and H9) were grown as described previously, and the large-scale differentiation performed after minor modifications of the protocol of Wu et al. (1) . Cells were harvested at times indicated in Fig. 1B and shRNA inserts recovered by PCR of total genomic DNA, following procedures based on the method by Bassik M. et al. (11) . shRNAs were quantitated by highthroughput sequencing. Hits for gene targets were classified and analyzed using various methods, including RIGER (21) . Additional details of the primary shRNA library screen, data analysis, and hit confirmation are described above and in the SI Methods. See Table S8 for primer sequences for real-time qPCR of validated target genes. The ASD and MR/ID-related gene list used for cross reference was compiled from the literature using recent, large-scale, reproduced genomic datasets from affected and control subjects (SI Methods). The relative proportion of ASD and MR/ID-associated gene targets was estimated by comparing the number of these gene hits with the total number of genes in the same phenotypic category at the end of neural differentiation. "Total changed " group indicates all genes whose shRNAs were absent, enriched or depleted at the end of neural differentiation; all other categories defined as described in Fig. 2A and Table 1 . The Enriched and Depleted categories were combined for this analysis and together indicate those genes whose shRNA was differently represented in PSA-NCAM-positive and -negative cells at the end of the differentiation. The relative proportion of the ASD-and MR/intellectual disability-related gene targets in each category was then compared and statistical significance was calculated as described in Table 1 . The values in bold indicate significant differences. There was significant enrichment of ASD and nonsyndromic MR/ID gene targets among those genes whose shRNA abundances changed during neural differentiation.
